Granahan Investment Management, LLC Renalytix PLC Transaction History

Granahan Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $1.61 $80,907 - $394,731	-245,175 Reduced 76.27%	76,298 $29,000
Q3 2023 Nov 14, 2023	BUY	$1.51 - $4.01 $457,116 - $1.21 Million	302,726 Added 1614.8%	321,473 $514,000
Q2 2023 Aug 14, 2023	BUY	$2.0 - $2.92 $15,354 - $22,416	7,677 Added 69.35%	18,747 $54,000
Q1 2023 May 15, 2023	BUY	$1.93 - $3.72 $21,365 - $41,180	11,070 New	11,070 $26,000
Q2 2022 Aug 15, 2022	SELL	$2.45 - $7.81 $14,896 - $47,484	-6,080 Reduced 1.84%	324,199 $794,000
Q1 2022 May 16, 2022	SELL	$5.88 - $15.9 $1.12 Million - $3.04 Million	-190,969 Reduced 36.64%	330,279 $2.29 Million
Q4 2021 Feb 14, 2022	BUY	$13.43 - $27.4 $313,160 - $638,913	23,318 Added 4.68%	521,248 $8.29 Million
Q3 2021 Nov 15, 2021	BUY	$17.91 - $34.78 $8.92 Million - $17.3 Million	497,930 New	497,930 $9.98 Million

3.88M

13.7K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.